| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.967 | 0.002 | 0.967 | Dopamine antagonist | 0.894 0.003 CID_15959407 0.078 0.048 CID_132263367 0.602 0.004 CID_2772144 | ||
| 0.961 | 0.002 | 0.961 | Dopamine D2 antagonist | 0.898 0.003 CID_15959407 0.063 0.048 CID_132263367 0.584 0.004 CID_2772144 | ||
| 0.961 | 0.002 | 0.981 | 5 Hydroxytryptamine antagonist | 0.981 0.002 CID_15959407 0.101 0.078 CID_132263367 0.78 0.004 CID_2772144 | CID_15959407 | |
| 0.958 | 0.002 | 0.974 | 5 Hydroxytryptamine 2 antagonist | 0.974 0.002 CID_15959407 0.128 0.054 CID_132263367 0.736 0.004 CID_2772144 | CID_15959407 | |
| 0.938 | 0.002 | 0.967 | 5 Hydroxytryptamine 2A antagonist | 0.967 0.002 CID_15959407 0.106 0.043 CID_132263367 0.665 0.003 CID_2772144 | CID_15959407 | |
| 0.921 | 0.002 | 0.921 | 5 Hydroxytryptamine 2C antagonist | 0.282 0.01 CID_15959407 0.101 0.044 CID_132263367 0.704 0.003 CID_2772144 | ||
| 0.912 | 0.002 | 0.912 | 5 Hydroxytryptamine 2B antagonist | 0.351 0.011 CID_15959407 0.14 0.046 CID_132263367 0.729 0.003 CID_2772144 | ||
| 0.903 | 0.002 | 0.927 | 5 Hydroxytryptamine 1A antagonist | 0.927 0.002 CID_15959407 0.627 0.004 CID_2772144 | CID_15959407 | |
| 0.898 | 0.002 | 0.919 | 5 Hydroxytryptamine 1 antagonist | 0.919 0.002 CID_15959407 0.62 0.004 CID_2772144 | CID_15959407 | |
| 0.895 | 0.003 | 0.895 | Dopamine D4 antagonist | 0.233 0.01 CID_15959407 0.094 0.028 CID_132263367 0.186 0.014 CID_2772144 | ||
| 0.858 | 0.003 | 0.979 | 5 Hydroxytryptamine 1A agonist | 0.464 0.004 CID_15959407 0.979 0.002 CID_2772144 | CID_2772144 | |
| 0.819 | 0.003 | 0.904 | Alpha adrenoreceptor antagonist | 0.904 0.003 CID_15959407 0.612 0.004 CID_2772144 | CID_15959407 | |
| 0.799 | 0.003 | 0.885 | Alpha 1a adrenoreceptor antagonist | 0.885 0.002 CID_15959407 0.512 0.004 CID_2772144 | CID_15959407 | |
| 0.791 | 0.003 | 0.884 | Alpha 1 adrenoreceptor antagonist | 0.884 0.002 CID_15959407 0.516 0.005 CID_2772144 | CID_15959407 | |
| 0.773 | 0.002 | 0.846 | Alpha 1b adrenoreceptor antagonist | 0.846 0.002 CID_15959407 0.533 0.004 CID_2772144 | CID_15959407 | |
| 0.731 | 0.004 | 0.858 | 5 Hydroxytryptamine 1 agonist | 0.345 0.005 CID_15959407 0.858 0.003 CID_2772144 | CID_2772144 | |
| 0.724 | 0.002 | 0.818 | Alpha 1d adrenoreceptor antagonist | 0.818 0.002 CID_15959407 0.503 0.004 CID_2772144 | CID_15959407 | |
| 0.672 | 0.005 | 0.696 | HERG channel blocker | 0.29 0.051 CID_15959407 0.696 0.005 CID_2772144 | CID_2772144 | |
| 0.646 | 0.005 | 0.675 | Potassium channel (Voltage-sensitive) blocker | 0.28 0.056 CID_15959407 0.675 0.005 CID_2772144 | CID_2772144 | |
| 0.624 | 0.005 | 0.943 | Antiadrenergic | 0.943 0.003 CID_15959407 0.846 0.004 CID_2772144 | CID_15959407 | |
| 0.623 | 0.005 | 0.943 | Adrenaline antagonist | 0.943 0.003 CID_15959407 0.846 0.004 CID_2772144 | CID_15959407 | |
| 0.616 | 0.004 | 0.854 | 5 Hydroxytryptamine agonist | 0.247 0.011 CID_15959407 0.071 0.046 CID_132263367 0.854 0.003 CID_2772144 | CID_2772144 | |
| 0.611 | 0.004 | 0.745 | 5 Hydroxytryptamine 7 antagonist | 0.269 0.007 CID_15959407 0.745 0.003 CID_2772144 | CID_2772144 | |
| 0.525 | 0.004 | 0.648 | 5 Hydroxytryptamine 1F antagonist | 0.284 0.006 CID_15959407 0.096 0.034 CID_132263367 0.648 0.003 CID_2772144 | CID_2772144 | |
| 0.468 | 0.014 | 0.472 | Potassium channel blocker | 0.155 0.131 CID_15959407 0.472 0.013 CID_2772144 | CID_2772144 | |
| 0.425 | 0.004 | 0.497 | Alpha 1 adrenoreceptor agonist | 0.081 0.023 CID_15959407 0.497 0.003 CID_2772144 | CID_2772144 | |
| 0.417 | 0.004 | 0.417 | Dopamine D1 antagonist | 0.097 0.026 CID_15959407 0.067 0.043 CID_132263367 0.256 0.008 CID_2772144 | ||
| 0.371 | 0.005 | 0.371 | Dopamine D3 antagonist | 0.105 0.023 CID_15959407 0.058 0.047 CID_132263367 0.121 0.02 CID_2772144 | ||
| 0.355 | 0.004 | 0.355 | 5 Hydroxytryptamine 1B antagonist | 0.109 0.02 CID_15959407 0.091 0.028 CID_132263367 0.163 0.011 CID_2772144 | ||
| 0.34 | 0.003 | 0.34 | 5 Hydroxytryptamine 2A agonist | 0.103 0.013 CID_15959407 0.223 0.004 CID_132263367 0.249 0.004 CID_2772144 | ||
| 0.314 | 0.004 | 0.314 | 5 Hydroxytryptamine 1D antagonist | 0.097 0.024 CID_15959407 0.087 0.028 CID_132263367 0.152 0.012 CID_2772144 | ||
| 0.313 | 0.005 | 0.425 | Alpha adrenoreceptor agonist | 0.068 0.047 CID_15959407 0.077 0.04 CID_132263367 0.425 0.004 CID_2772144 | CID_2772144 | |
| 0.309 | 0.006 | 0.309 | Alpha 2a adrenoreceptor antagonist | 0.106 0.034 CID_15959407 0.076 0.052 CID_132263367 0.242 0.01 CID_2772144 | ||
| 0.358 | 0.086 | 0.574 | MAP kinase kinase 6 inhibitor | 0.574 0.008 CID_2772144 | CID_2772144 | |
| 0.249 | 0.007 | 0.249 | Sigma receptor antagonist | 0.049 0.035 CID_15959407 0.195 0.009 CID_2772144 | ||
| 0.25 | 0.032 | 0.34 | MAP kinase kinase 3 inhibitor | 0.34 0.004 CID_2772144 | CID_2772144 | |
| 0.236 | 0.029 | 0.239 | Acetylcholine M1 receptor antagonist | 0.118 0.111 CID_15959407 0.124 0.103 CID_132263367 0.239 0.028 CID_2772144 | CID_2772144 | |
| 0.204 | 0.014 | 0.204 | Histamine H1 receptor antagonist | 0.105 0.038 CID_2772144 | ||
| 0.188 | 0.012 | 0.357 | 5 Hydroxytryptamine uptake inhibitor | 0.054 0.052 CID_15959407 0.357 0.005 CID_2772144 | CID_2772144 | |
| 0.302 | 0.14 | 0.302 | Analgesic | |||
| 0.178 | 0.021 | 0.197 | Alpha 2 adrenoreceptor antagonist | 0.197 0.018 CID_2772144 | CID_2772144 | |
| 0.163 | 0.013 | 0.168 | Dopamine agonist | 0.096 0.029 CID_15959407 0.168 0.013 CID_132263367 | CID_132263367 | |
| 0.175 | 0.03 | 0.175 | Alpha 2b adrenoreceptor antagonist | 0.123 0.056 CID_15959407 0.156 0.036 CID_132263367 0.107 0.069 CID_2772144 | ||
| 0.198 | 0.062 | 0.198 | Sigma receptor agonist | 0.154 0.083 CID_15959407 | ||
| 0.143 | 0.009 | 0.316 | DNA gyrase inhibitor | 0.316 0.004 CID_2772144 | CID_2772144 | |
| 0.139 | 0.007 | 0.139 | Dopamine D2 agonist | 0.077 0.015 CID_15959407 0.099 0.011 CID_132263367 | ||
| 0.165 | 0.063 | 0.248 | Hexokinase inhibitor | 0.155 0.073 CID_132263367 0.248 0.017 CID_2772144 | CID_2772144 | |
| 0.109 | 0.008 | 0.168 | 5 Hydroxytryptamine 2 agonist | 0.048 0.041 CID_15959407 0.168 0.005 CID_132263367 0.129 0.006 CID_2772144 | CID_132263367 | |
| 0.104 | 0.006 | 0.288 | Sigma 1 receptor antagonist | 0.288 0.004 CID_2772144 | CID_2772144 | |
| 0.226 | 0.129 | 0.232 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.2 0.157 CID_15959407 0.232 0.124 CID_132263367 | CID_132263367 | |
| 0.148 | 0.052 | 0.401 | Glutamate receptor antagonist | 0.401 0.005 CID_132263367 | CID_132263367 | |
| 0.132 | 0.037 | 0.132 | Multidrug resistance-associated protein 1 inhibitor | 0.119 0.049 CID_15959407 | ||
| 0.107 | 0.013 | 0.184 | 5 Hydroxytryptamine 6 antagonist | 0.063 0.034 CID_15959407 0.184 0.004 CID_2772144 | CID_2772144 | |
| 0.181 | 0.093 | 0.181 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.149 0.129 CID_2772144 | ||
| 0.139 | 0.051 | 0.154 | Acetylcholine muscarinic antagonist | 0.154 0.041 CID_2772144 | CID_2772144 | |
| 0.129 | 0.042 | 0.137 | AMP-activated protein kinase stimulant | 0.137 0.037 CID_132263367 0.129 0.042 CID_2772144 | CID_132263367 | |
| 0.13 | 0.043 | 0.13 | Alpha 2c adrenoreceptor antagonist | 0.086 0.08 CID_15959407 0.112 0.055 CID_132263367 0.094 0.072 CID_2772144 | ||
| 0.11 | 0.024 | 0.294 | Cyclin B3 inhibitor | 0.094 0.031 CID_15959407 0.294 0.004 CID_132263367 | CID_132263367 | |
| 0.098 | 0.018 | 0.098 | Acetylcholine M5 receptor antagonist | 0.055 0.05 CID_132263367 0.073 0.029 CID_2772144 | ||
| 0.11 | 0.041 | 0.249 | Acetylcholine agonist | 0.249 0.009 CID_2772144 | CID_2772144 | |
| 0.133 | 0.075 | 0.133 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.122 0.082 CID_132263367 | ||
| 0.108 | 0.049 | 0.108 | Antihistaminic | 0.106 0.05 CID_2772144 | ||
| 0.08 | 0.025 | 0.585 | NMDA 2C receptor antagonist | 0.058 0.048 CID_15959407 0.585 0.003 CID_132263367 | CID_132263367 | |
| 0.091 | 0.036 | 0.093 | Acetylcholine M4 receptor antagonist | 0.076 0.05 CID_132263367 0.093 0.034 CID_2772144 | CID_2772144 | |
| 0.099 | 0.048 | 0.099 | Histamine antagonist | 0.098 0.049 CID_2772144 | ||
| 0.06 | 0.028 | 0.081 | Acetylcholine M2 receptor agonist | 0.081 0.013 CID_2772144 | CID_2772144 | |
| 0.182 | 0.152 | 0.267 | 5 Hydroxytryptamine 1E antagonist | 0.267 0.057 CID_132263367 0.212 0.117 CID_2772144 | CID_132263367 | |
| 0.059 | 0.033 | 0.071 | 5 Hydroxytryptamine 7 agonist | 0.071 0.019 CID_132263367 | CID_132263367 | |
| 0.049 | 0.023 | 0.049 | Antidiuretic hormone antagonist | 0.036 0.03 CID_132263367 | ||
| 0.083 | 0.057 | 0.141 | Acetylcholine M3 receptor agonist | 0.073 0.068 CID_15959407 0.141 0.024 CID_132263367 | CID_132263367 | |
| 0.081 | 0.056 | 0.097 | Adrenaline agonist | 0.091 0.045 CID_132263367 0.097 0.039 CID_2772144 | CID_2772144 | |
| 0.04 | 0.017 | 0.04 | Vasopressin 1 antagonist | 0.028 0.027 CID_2772144 | ||
| 0.073 | 0.051 | 0.1 | Lipase inhibitor | 0.1 0.027 CID_2772144 | CID_2772144 | |
| 0.054 | 0.033 | 0.094 | Factor IXa inhibitor | 0.094 0.011 CID_2772144 | CID_2772144 | |
| 0.041 | 0.021 | 0.16 | DNA gyrase subunit B inhibitor | 0.16 0.004 CID_2772144 | CID_2772144 | |
| 0.044 | 0.024 | 0.055 | Dopamine D3 agonist | 0.037 0.031 CID_15959407 0.055 0.016 CID_132263367 | CID_132263367 | |
| 0.036 | 0.017 | 0.083 | Acetylcholine M4 receptor agonist | 0.031 0.021 CID_132263367 0.083 0.005 CID_2772144 | CID_2772144 | |
| 0.062 | 0.043 | 0.156 | Adrenaline uptake inhibitor | 0.156 0.009 CID_2772144 | CID_2772144 | |
| 0.035 | 0.017 | 0.035 | Vasopressin 1A antagonist | 0.031 0.018 CID_2772144 | ||
| 0.038 | 0.025 | 0.05 | Glucose-6-phosphate dehydrogenase inhibitor | 0.05 0.012 CID_2772144 | CID_2772144 | |
| 0.078 | 0.066 | 0.096 | Caspase 7 inhibitor | 0.096 0.033 CID_2772144 | CID_2772144 | |
| 0.049 | 0.037 | 0.049 | Dopamine D4 agonist | |||
| 0.054 | 0.043 | 0.091 | 5 Hydroxytryptamine 3 antagonist | 0.091 0.02 CID_2772144 | CID_2772144 | |
| 0.101 | 0.091 | 0.148 | Acetylcholine antagonist | 0.148 0.051 CID_2772144 | CID_2772144 | |
| 0.052 | 0.044 | 0.165 | Cyclin B2 inhibitor | 0.165 0.005 CID_132263367 | CID_132263367 | |
| 0.101 | 0.094 | 0.15 | Cholinergic antagonist | 0.15 0.052 CID_2772144 | CID_2772144 | |
| 0.043 | 0.038 | 0.057 | Melanocortin antagonist | 0.057 0.023 CID_132263367 | CID_132263367 | |
| 0.193 | 0.188 | 0.215 | Apoptosis antagonist | 0.215 0.162 CID_132263367 | CID_132263367 | |
| 0.06 | 0.056 | 0.115 | 5 Hydroxytryptamine 3A antagonist | 0.115 0.01 CID_2772144 | CID_2772144 | |
| 0.053 | 0.053 | 0.156 | Cyclin B1 inhibitor | 0.156 0.005 CID_132263367 | CID_132263367 | |
| 0.108 | 0.108 | 0.163 | Interleukin 1 antagonist | 0.163 0.05 CID_2772144 | CID_2772144 | |
| 0.061 | 0.061 | 0.508 | NMDA 2 receptor antagonist | 0.508 0.004 CID_132263367 | CID_132263367 | |
| 0.046 | 0.049 | 0.153 | Acetylcholine muscarinic agonist | 0.153 0.01 CID_2772144 | CID_2772144 | |
| 0.035 | 0.043 | 0.141 | 5 Hydroxytryptamine 2C agonist | 0.078 0.011 CID_132263367 0.141 0.005 CID_2772144 | CID_2772144 | |
| 0.019 | 0.029 | 0.023 | Melanocortin 5 antagonist | 0.023 0.021 CID_132263367 | CID_132263367 | |
| 0.032 | 0.044 | 0.052 | Melanocortin 4 antagonist | 0.052 0.022 CID_132263367 | CID_132263367 | |
| 0.044 | 0.057 | 0.152 | Cyclin B inhibitor | 0.152 0.005 CID_132263367 | CID_132263367 | |
| 0.085 | 0.104 | 0.149 | Interleukin 1b antagonist | 0.149 0.041 CID_2772144 | CID_2772144 | |
| 0.03 | 0.05 | 0.145 | Acetylcholine M1 receptor agonist | 0.145 0.008 CID_2772144 | CID_2772144 | |
| 0.132 | 0.153 | 0.442 | Anticonvulsant | 0.442 0.017 CID_132263367 | CID_132263367 | |
| 0.063 | 0.093 | 0.518 | NMDA receptor antagonist | 0.518 0.004 CID_132263367 | CID_132263367 | |
| 0.011 | 0.041 | 0.024 | Dopamine autoreceptor agonist | 0.024 0.016 CID_132263367 | CID_132263367 | |
| 0.027 | 0.058 | 0.065 | CDK5/p25 inhibitor | 0.065 0.013 CID_132263367 | CID_132263367 | |
| 0.02 | 0.061 | 0.043 | 5 Hydroxytryptamine 3B antagonist | 0.043 0.019 CID_2772144 | CID_2772144 | |
| 0.011 | 0.054 | 0.059 | Nociceptin (N/OFQ) receptor antagonist | 0.059 0.01 CID_132263367 | CID_132263367 | |
| 0.035 | 0.08 | 0.08 | Nicotinic alpha7 receptor agonist | 0.08 0.018 CID_2772144 | CID_2772144 | |
| 0.135 | 0.18 | 0.165 | Spasmolytic | 0.165 0.149 CID_2772144 | CID_2772144 | |
| 0.033 | 0.079 | 0.098 | Nicotinic neuronal receptor agonist | 0.098 0.013 CID_2772144 | CID_2772144 | |
| 0.054 | 0.102 | 0.154 | Acetylcholine nicotinic agonist | 0.154 0.016 CID_2772144 | CID_2772144 | |
| 0.027 | 0.076 | 0.119 | 5 Hydroxytryptamine 2B agonist | 0.119 0.004 CID_132263367 0.048 0.015 CID_2772144 | CID_132263367 | |
| 0.245 | 0.296 | 0.437 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.437 0.071 CID_132263367 0.371 0.128 CID_2772144 | CID_132263367 | |
| 0.022 | 0.075 | 0.051 | p53 inhibitor | 0.051 0.013 CID_132263367 | CID_132263367 | |
| 0.008 | 0.062 | 0.018 | Kainate receptor 3 antagonist | 0.018 0.011 CID_132263367 | CID_132263367 | |
| 0.01 | 0.065 | 0.043 | Kainate receptor 4 antagonist | 0.043 0.008 CID_132263367 | CID_132263367 | |
| 0.011 | 0.068 | 0.024 | Bombesin agonist | 0.024 0.013 CID_2772144 | CID_2772144 | |
| 0.01 | 0.068 | 0.02 | Bombesin 3 receptor agonist | 0.02 0.011 CID_2772144 | CID_2772144 | |
| 0.136 | 0.194 | 0.334 | Cardiotonic | 0.334 0.044 CID_132263367 | CID_132263367 | |
| 0.014 | 0.074 | 0.14 | Kainate receptor 2 antagonist | 0.14 0.004 CID_132263367 | CID_132263367 | |
| 0.021 | 0.085 | 0.341 | NMDA 2A receptor antagonist | 0.341 0.004 CID_132263367 | CID_132263367 | |
| 0.112 | 0.18 | 0.134 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.134 0.132 CID_132263367 | CID_132263367 | |
| 0.153 | 0.223 | 0.273 | Transcription factor NF kappa B inhibitor | 0.223 0.148 CID_132263367 0.273 0.111 CID_2772144 | CID_2772144 | |
| 0.024 | 0.095 | 0.075 | AMPA 4 receptor antagonist | 0.075 0.007 CID_132263367 | CID_132263367 | |
| 0.011 | 0.083 | 0.036 | Dipeptidyl peptidase I inhibitor | 0.036 0.015 CID_132263367 | CID_132263367 | |
| 0.055 | 0.128 | 0.127 | Urease inhibitor | 0.099 0.068 CID_132263367 0.127 0.038 CID_2772144 | CID_2772144 | |
| 0.074 | 0.15 | 0.134 | Ribosomal protein S6 kinase inhibitor | 0.134 0.078 CID_2772144 | CID_2772144 | |
| 0.017 | 0.099 | 0.033 | Melanocortin 1 antagonist | 0.033 0.032 CID_132263367 | CID_132263367 | |
| 0.028 | 0.112 | 0.043 | DNA gyrase subunit A inhibitor | 0.043 0.027 CID_2772144 | CID_2772144 | |
| 0.036 | 0.122 | 0.073 | Check point kinase 1 inhibitor | 0.073 0.043 CID_132263367 | CID_132263367 | |
| 0.024 | 0.114 | 0.044 | Phenylethanolamine N methyltransferase inhibitor | 0.044 0.022 CID_2772144 | CID_2772144 | |
| 0.021 | 0.112 | 0.264 | NMDA receptor subunit 3B antagonist | 0.264 0.004 CID_132263367 | CID_132263367 | |
| 0.172 | 0.264 | 0.259 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.259 0.055 CID_2772144 | CID_2772144 | |
| 0.007 | 0.105 | 0.024 | Kainate receptor 5 antagonist | 0.024 0.012 CID_132263367 | CID_132263367 | |
| 0.053 | 0.154 | 0.112 | Polo-like kinase-4 inhibitor | 0.112 0.064 CID_132263367 | CID_132263367 | |
| 0.028 | 0.136 | 0.047 | Histamine H4 receptor antagonist | 0.047 0.036 CID_2772144 | CID_2772144 | |
| 0.035 | 0.144 | 0.094 | CXC chemokine receptor antagonist | 0.094 0.028 CID_132263367 | CID_132263367 | |
| 0.034 | 0.143 | 0.078 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.078 0.052 CID_132263367 | CID_132263367 | |
| 0.07 | 0.183 | 0.164 | NADPH oxidase inhibitor | 0.164 0.047 CID_132263367 0.105 0.104 CID_2772144 | CID_132263367 | |
| 0.024 | 0.138 | 0.07 | H+/K+-transporting ATPase inhibitor | 0.07 0.017 CID_2772144 | CID_2772144 | |
| 0.053 | 0.168 | 0.09 | Insulin receptor antagonist | 0.09 0.078 CID_132263367 | CID_132263367 | |
| 0.01 | 0.132 | 0.04 | AMPA receptor agonist | 0.04 0.017 CID_2772144 | CID_2772144 | |
| 0.026 | 0.149 | 0.056 | NMDA 2B receptor antagonist | 0.056 0.034 CID_132263367 | CID_132263367 | |
| 0.022 | 0.147 | 0.046 | Histamine H1 receptor agonist | 0.046 0.025 CID_132263367 0.043 0.031 CID_2772144 | CID_132263367 | |
| 0.083 | 0.212 | 0.186 | Cyclin-dependent kinase 8 inhibitor | 0.121 0.116 CID_132263367 0.186 0.046 CID_2772144 | CID_2772144 | |
| 0.129 | 0.26 | 0.199 | ErbB-1 antagonist | 0.199 0.09 CID_132263367 | CID_132263367 | |
| 0.045 | 0.177 | 0.207 | Cyclin-dependent kinase 5 inhibitor | 0.207 0.021 CID_132263367 | CID_132263367 | |
| 0.045 | 0.178 | 0.238 | M18 aspartyl aminopeptidase inhibitor | 0.238 0.023 CID_2772144 | CID_2772144 | |
| 0.04 | 0.174 | 0.199 | Glycine receptor antagonist | 0.199 0.004 CID_132263367 | CID_132263367 | |
| 0.008 | 0.145 | 0.029 | AMPA 2 receptor antagonist | 0.029 0.021 CID_132263367 | CID_132263367 | |
| 0.034 | 0.173 | 0.161 | Cyclin-dependent kinase 1 inhibitor | 0.161 0.037 CID_132263367 | CID_132263367 | |
| 0.005 | 0.145 | 0.239 | NMDA receptor glycine site antagonist | 0.239 0.003 CID_132263367 | CID_132263367 | |
| 0.045 | 0.188 | 0.095 | Glycogen synthase kinase-3 inhibitor | 0.095 0.084 CID_132263367 | CID_132263367 | |
| 0.012 | 0.155 | 0.048 | Histone deacetylase 8 inhibitor | 0.048 0.023 CID_132263367 | CID_132263367 | |
| 0.048 | 0.192 | 0.132 | Glycogen synthase kinase-3 alpha inhibitor | 0.132 0.077 CID_132263367 | CID_132263367 | |
| 0.093 | 0.237 | 0.163 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.163 0.051 CID_132263367 | CID_132263367 | |
| 0.007 | 0.154 | 0.031 | Imidazoline I1 receptor antagonist | 0.031 0.006 CID_132263367 0.023 0.012 CID_2772144 | CID_132263367 | |
| 0.011 | 0.159 | 0.204 | NMDA receptor subunit 3A antagonist | 0.204 0.004 CID_132263367 | CID_132263367 | |
| 0.105 | 0.255 | 0.182 | Death-associated protein kinase 2 inhibitor | 0.182 0.052 CID_132263367 | CID_132263367 | |
| 0.008 | 0.158 | 0.021 | Progesterone receptor B antagonist | 0.021 0.01 CID_132263367 | CID_132263367 | |
| 0.02 | 0.171 | 0.051 | Thymidine kinase inhibitor | 0.051 0.018 CID_132263367 | CID_132263367 | |
| 0.033 | 0.184 | 0.063 | Glutamate (mGluR group I) antagonist | 0.063 0.059 CID_132263367 | CID_132263367 | |
| 0.041 | 0.194 | 0.1 | Glycogen synthase kinase-3 beta inhibitor | 0.1 0.077 CID_132263367 | CID_132263367 | |
| 0.023 | 0.178 | 0.069 | Purinergic P2X4 antagonist | 0.069 0.01 CID_132263367 | CID_132263367 | |
| 0.032 | 0.188 | 0.084 | Glutamate (mGluR) antagonist | 0.084 0.046 CID_132263367 | CID_132263367 | |
| 0.058 | 0.215 | 0.132 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.132 0.103 CID_132263367 | CID_132263367 | |
| 0.009 | 0.169 | 0.036 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.036 0.004 CID_132263367 | CID_132263367 | |
| 0.007 | 0.169 | 0.05 | AMPA 3 receptor antagonist | 0.05 0.009 CID_132263367 | CID_132263367 | |
| 0.032 | 0.194 | 0.108 | Corticotropin releasing factor 2 receptor antagonist | 0.108 0.005 CID_132263367 | CID_132263367 | |
| 0.003 | 0.165 | 0.04 | Kainate receptor 1 antagonist | 0.04 0.007 CID_132263367 | CID_132263367 | |
| 0.125 | 0.289 | 0.2 | Neuropeptide Y2 antagonist | 0.2 0.12 CID_132263367 | CID_132263367 | |
| 0.046 | 0.211 | 0.182 | 5 Hydroxytryptamine 3A agonist | 0.12 0.056 CID_132263367 0.182 0.021 CID_2772144 | CID_2772144 | |
| 0.018 | 0.184 | 0.058 | CDK1/cyclin B inhibitor | 0.058 0.048 CID_132263367 | CID_132263367 | |
| 0.009 | 0.177 | 0.041 | Nicotinic acid receptor agonist | 0.041 0.02 CID_132263367 0.034 0.028 CID_2772144 | CID_132263367 | |
| 0.007 | 0.178 | 0.045 | Kinesin-like protein 1 inhibitor | 0.045 0.019 CID_132263367 | CID_132263367 | |
| 0.007 | 0.178 | 0.045 | Kinesin antagonist | 0.045 0.019 CID_132263367 | CID_132263367 | |
| 0.028 | 0.2 | 0.109 | 5 Hydroxytryptamine 3 agonist | 0.109 0.012 CID_2772144 | CID_2772144 | |
| 0.023 | 0.197 | 0.086 | Cannabinoid receptor antagonist | 0.086 0.036 CID_132263367 | CID_132263367 | |
| 0.003 | 0.178 | 0.079 | AMPA 1 receptor antagonist | 0.079 0.007 CID_132263367 | CID_132263367 | |
| 0.046 | 0.22 | 0.104 | MDM2 inhibitor | 0.104 0.005 CID_132263367 | CID_132263367 | |
| 0.027 | 0.208 | 0.086 | Phospholipase D inhibitor | 0.086 0.026 CID_132263367 0.073 0.046 CID_2772144 | CID_132263367 | |
| 0.098 | 0.284 | 0.152 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.152 0.131 CID_132263367 | CID_132263367 | |
| 0.007 | 0.193 | 0.013 | DNA polymerase III polC-type inhibitor | 0.013 0.01 CID_132263367 | CID_132263367 | |
| 0.007 | 0.195 | 0.142 | Kainate receptor antagonist | 0.142 0.005 CID_132263367 | CID_132263367 | |
| 0.027 | 0.22 | 0.079 | Cathepsin G inhibitor | 0.079 0.045 CID_132263367 | CID_132263367 | |
| 0.046 | 0.245 | 0.125 | Proteasome inhibitor | 0.125 0.062 CID_2772144 | CID_2772144 | |
| 0.006 | 0.211 | 0.025 | Melatonin antagonist | 0.025 0.024 CID_132263367 | CID_132263367 | |
| 0.023 | 0.23 | 0.055 | Alpha 1L adrenoreceptor agonist | 0.055 0.011 CID_2772144 | CID_2772144 | |
| 0.052 | 0.26 | 0.093 | Alpha 2d adrenoreceptor antagonist | 0.093 0.063 CID_132263367 0.087 0.079 CID_2772144 | CID_132263367 | |
| 0.015 | 0.226 | 0.077 | Acetylcholine M5 receptor agonist | 0.077 0.036 CID_132263367 0.071 0.043 CID_2772144 | CID_132263367 | |
| 0.099 | 0.315 | 0.143 | Cyclin-dependent kinase 3 inhibitor | 0.143 0.113 CID_132263367 | CID_132263367 | |
| 0.052 | 0.267 | 0.105 | Nav1.5 sodium channel blocker | 0.105 0.076 CID_132263367 | CID_132263367 | |
| 0.09 | 0.307 | 0.43 | Cyclic AMP phosphodiesterase inhibitor | 0.43 0.013 CID_132263367 | CID_132263367 | |
| 0.009 | 0.228 | 0.047 | Phosphodiesterase 3B inhibitor | 0.047 0.028 CID_132263367 | CID_132263367 | |
| 0.016 | 0.236 | 0.076 | Alpha 2 adrenoreceptor agonist | 0.076 0.026 CID_132263367 0.061 0.041 CID_2772144 | CID_132263367 | |
| 0.019 | 0.239 | 0.074 | Cannabinoid CB1 receptor antagonist | 0.074 0.031 CID_132263367 | CID_132263367 | |
| 0.07 | 0.291 | 0.14 | Death-associated protein kinase 3 inhibitor | 0.14 0.139 CID_2772144 | CID_2772144 | |
| 0.033 | 0.254 | 0.117 | Protein kinase C delta inhibitor | 0.117 0.039 CID_2772144 | CID_2772144 | |
| 0.053 | 0.276 | 0.138 | Toll-Like receptor antagonist | 0.138 0.065 CID_2772144 | CID_2772144 | |
| 0.081 | 0.309 | 0.222 | Neurotrophic factor enhancer | 0.222 0.058 CID_132263367 | CID_132263367 | |
| 0.029 | 0.257 | 0.06 | Bcl2 antagonist | 0.06 0.056 CID_15959407 | CID_15959407 | |
| 0.115 | 0.344 | 0.246 | Insulysin inhibitor | 0.236 0.11 CID_132263367 0.246 0.1 CID_2772144 | CID_2772144 | |
| 0.109 | 0.339 | 0.258 | 15-Lipoxygenase inhibitor | 0.258 0.159 CID_132263367 | CID_132263367 | |
| 0.126 | 0.357 | 0.205 | 5 Hydroxytryptamine 3E antagonist | 0.181 0.103 CID_132263367 0.205 0.055 CID_2772144 | CID_2772144 | |
| 0.015 | 0.247 | 0.036 | Nicotinic acid receptor 1 agonist | 0.036 0.035 CID_132263367 | CID_132263367 | |
| 0.006 | 0.238 | 0.033 | Farnesoid X receptor agonist | 0.033 0.032 CID_132263367 | CID_132263367 | |
| 0.004 | 0.237 | 0.053 | Methionyl aminopeptidase 2 inhibitor | 0.053 0.006 CID_132263367 | CID_132263367 | |
| 0.009 | 0.241 | 0.158 | Glutamate (mGluR1) antagonist | 0.158 0.006 CID_132263367 | CID_132263367 | |
| 0.023 | 0.263 | 0.145 | NMDA receptor agonist | 0.145 0.009 CID_132263367 | CID_132263367 | |
| 0.023 | 0.267 | 0.069 | Beta adrenoreceptor antagonist | 0.069 0.04 CID_132263367 | CID_132263367 | |
| 0.039 | 0.284 | 0.116 | Nav1.6 sodium channel blocker | 0.116 0.102 CID_132263367 | CID_132263367 | |
| 0.008 | 0.258 | 0.022 | Factor XIII inhibitor | 0.022 0.012 CID_2772144 | CID_2772144 | |
| 0.006 | 0.257 | 0.042 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.03 CID_132263367 | CID_132263367 | |
| 0.006 | 0.259 | 0.037 | Carnitine palmitoyltransferase 1 inhibitor | 0.037 0.019 CID_132263367 | CID_132263367 | |
| 0.113 | 0.368 | 0.331 | Nitric-oxide synthase stimulant | 0.331 0.006 CID_132263367 | CID_132263367 | |
| 0.038 | 0.294 | 0.175 | DNA directed RNA polymerase inhibitor | 0.175 0.018 CID_132263367 | CID_132263367 | |
| 0.024 | 0.285 | 0.076 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.076 0.022 CID_132263367 | CID_132263367 | |
| 0.014 | 0.276 | 0.062 | GABA A receptor antagonist | 0.062 0.029 CID_132263367 | CID_132263367 | |
| 0.075 | 0.339 | 0.2 | Focal adhesion kinase 2 inhibitor | 0.2 0.069 CID_132263367 | CID_132263367 | |
| 0.007 | 0.273 | 0.029 | 5 Hydroxytryptamine 6 agonist | 0.029 0.02 CID_2772144 | CID_2772144 | |
| 0.006 | 0.275 | 0.036 | Carnitine palmitoyltransferase inhibitor | 0.036 0.021 CID_132263367 | CID_132263367 | |
| 0.009 | 0.28 | 0.037 | Factor XIa inhibitor | 0.037 0.034 CID_132263367 | CID_132263367 | |
| 0.079 | 0.351 | 0.122 | Death-associated protein kinase 1 inhibitor | 0.122 0.105 CID_132263367 | CID_132263367 | |
| 0.033 | 0.307 | 0.117 | MAP kinase kinase inhibitor | 0.117 0.076 CID_2772144 | CID_2772144 | |
| 0.011 | 0.287 | 0.138 | NMDA receptor glycine site agonist | 0.138 0.005 CID_132263367 | CID_132263367 | |
| 0.038 | 0.316 | 0.134 | Cytidine deaminase inhibitor | 0.134 0.088 CID_2772144 | CID_2772144 | |
| 0.012 | 0.292 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.033 0.008 CID_132263367 | CID_132263367 | |
| 0.004 | 0.287 | 0.03 | Endothelial nitric-oxide synthase inhibitor | 0.03 0.023 CID_132263367 | CID_132263367 | |
| 0.011 | 0.294 | 0.065 | GABA receptor antagonist | 0.065 0.028 CID_132263367 | CID_132263367 | |
| 0.042 | 0.331 | 0.117 | Activin receptor-like kinase 2 inhibitor | 0.115 0.103 CID_132263367 0.117 0.1 CID_2772144 | CID_2772144 | |
| 0.001 | 0.291 | 0.009 | DNA topoisomerase III inhibitor | 0.009 0.004 CID_132263367 | CID_132263367 | |
| 0.11 | 0.4 | 0.329 | Calcium channel activator | 0.329 0.065 CID_132263367 0.26 0.136 CID_2772144 | CID_132263367 | |
| 0.012 | 0.306 | 0.028 | DNA polymerase III inhibitor | 0.028 0.019 CID_132263367 | CID_132263367 | |
| 0.047 | 0.342 | 0.133 | MAP3K9 inhibitor | 0.133 0.088 CID_132263367 | CID_132263367 | |
| 0.012 | 0.307 | 0.112 | Benzodiazepine agonist | 0.112 0.019 CID_132263367 | CID_132263367 | |
| 0.025 | 0.33 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.076 0.026 CID_132263367 | CID_132263367 | |
| 0.005 | 0.309 | 0.045 | Glutamate (mGluR group II) antagonist | 0.045 0.019 CID_132263367 | CID_132263367 | |
| 0.03 | 0.337 | 0.162 | Toll-Like receptor 9 antagonist | 0.162 0.055 CID_2772144 | CID_2772144 | |
| 0.135 | 0.443 | 0.378 | Calcium channel L-type activator | 0.378 0.097 CID_132263367 | CID_132263367 | |
| 0.009 | 0.318 | 0.042 | Sphingosine 1-phosphate receptor agonist | 0.042 0.034 CID_132263367 | CID_132263367 | |
| 0.004 | 0.313 | 0.03 | Glutamate (mGluR2) antagonist | 0.03 0.02 CID_132263367 | CID_132263367 | |
| 0.004 | 0.313 | 0.03 | Prostaglandin EP3 antagonist | 0.03 0.021 CID_132263367 | CID_132263367 | |
| 0.016 | 0.327 | 0.058 | Potassium channel (ATP-sensitive) activator | 0.058 0.018 CID_132263367 0.044 0.043 CID_2772144 | CID_132263367 | |
| 0.032 | 0.345 | 0.263 | Psychostimulant | 0.263 0.054 CID_132263367 | CID_132263367 | |
| 0.01 | 0.324 | 0.07 | Nicotinic receptor alpha7 subunit antagonist | 0.07 0.021 CID_2772144 | CID_2772144 | |
| 0.017 | 0.331 | 0.061 | Potassium channel (Inward rectifier) activator | 0.061 0.019 CID_132263367 0.046 0.044 CID_2772144 | CID_132263367 | |
| 0.026 | 0.345 | 0.136 | Polo-like kinase-1 inhibitor | 0.136 0.023 CID_132263367 | CID_132263367 | |
| 0.007 | 0.326 | 0.044 | Dopamine D5 agonist | 0.044 0.022 CID_2772144 | CID_2772144 | |
| 0.094 | 0.414 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.142 0.066 CID_132263367 0.131 0.117 CID_2772144 | CID_132263367 | |
| 0.034 | 0.357 | 0.124 | Bromodomain-containing protein 2 inhibitor | 0.124 0.02 CID_132263367 | CID_132263367 | |
| 0.017 | 0.345 | 0.052 | Glutamate (mGluR4) antagonist | 0.052 0.019 CID_132263367 | CID_132263367 | |
| 0.034 | 0.363 | 0.164 | Electrolyte absorption antagonist | 0.164 0.015 CID_132263367 | CID_132263367 | |
| 0.013 | 0.344 | 0.164 | HIV-1 reverse transcriptase inhibitor | 0.164 0.012 CID_132263367 | CID_132263367 | |
| 0.005 | 0.337 | 0.08 | AMPA receptor antagonist | 0.08 0.017 CID_132263367 | CID_132263367 | |
| 0.029 | 0.373 | 0.114 | MAP kinase kinase 1 inhibitor | 0.114 0.041 CID_2772144 | CID_2772144 | |
| 0.014 | 0.359 | 0.073 | Protein kinase C beta inhibitor | 0.073 0.043 CID_2772144 | CID_2772144 | |
| 0.059 | 0.406 | 0.274 | Thyroid hormone beta antagonist | 0.274 0.103 CID_132263367 | CID_132263367 | |
| 0.01 | 0.359 | 0.059 | Neuronal nicotinic receptor antagonist | 0.059 0.056 CID_2772144 | CID_2772144 | |
| 0.015 | 0.366 | 0.038 | Kainate receptor agonist | 0.038 0.036 CID_132263367 | CID_132263367 | |
| 0.012 | 0.364 | 0.066 | Beta 1 adrenoreceptor antagonist | 0.066 0.03 CID_132263367 | CID_132263367 | |
| 0.021 | 0.375 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.044 CID_132263367 | CID_132263367 | |
| 0.08 | 0.434 | 0.321 | 5 Hydroxytryptamine release stimulant | 0.288 0.074 CID_132263367 0.321 0.064 CID_2772144 | CID_2772144 | |
| 0.1 | 0.454 | 0.255 | Tyrosine 3 hydroxylase inhibitor | 0.245 0.073 CID_132263367 0.255 0.063 CID_2772144 | CID_2772144 | |
| 0.013 | 0.374 | 0.052 | Beta 2 adrenoreceptor antagonist | 0.052 0.034 CID_132263367 | CID_132263367 | |
| 0.045 | 0.407 | 0.207 | Aldehyde oxidase inhibitor | 0.207 0.101 CID_132263367 0.201 0.104 CID_2772144 | CID_132263367 | |
| 0.021 | 0.383 | 0.05 | Parathyroid hormone antagonist | 0.05 0.022 CID_132263367 | CID_132263367 | |
| 0.009 | 0.374 | 0.071 | Cyclin-dependent kinase 6 inhibitor | 0.071 0.03 CID_2772144 | CID_2772144 | |
| 0.004 | 0.37 | 0.035 | Vascular adhesion protein 1 inhibitor | 0.035 0.033 CID_132263367 | CID_132263367 | |
| 0.016 | 0.383 | 0.047 | Glutamate (mGluR group III) antagonist | 0.047 0.025 CID_132263367 | CID_132263367 | |
| 0.007 | 0.376 | 0.049 | Glutamate (mGluR3) antagonist | 0.049 0.013 CID_132263367 | CID_132263367 | |
| 0.053 | 0.432 | 0.283 | Thyroid hormone antagonist | 0.283 0.103 CID_132263367 | CID_132263367 | |
| 0.054 | 0.439 | 0.135 | MAP kinase 3 inhibitor | 0.135 0.095 CID_132263367 | CID_132263367 | |
| 0.02 | 0.408 | 0.052 | Antiviral (Hepatitis D) | 0.052 0.033 CID_132263367 | CID_132263367 | |
| 0.098 | 0.487 | 0.262 | Interleukin 2 agonist | 0.262 0.106 CID_132263367 | CID_132263367 | |
| 0.025 | 0.414 | 0.097 | Beta glucuronidase inhibitor | 0.097 0.074 CID_132263367 | CID_132263367 | |
| 0.085 | 0.476 | 0.382 | GABA C receptor rho-3 antagonist | 0.382 0.07 CID_132263367 0.349 0.086 CID_2772144 | CID_132263367 | |
| 0.02 | 0.414 | 0.132 | Protein kinase C mu inhibitor | 0.132 0.035 CID_2772144 | CID_2772144 | |
| 0.015 | 0.412 | 0.051 | Sphingosine 1-phosphate receptor 1 antagonist | 0.051 0.05 CID_132263367 | CID_132263367 | |
| 0.041 | 0.438 | 0.108 | Histone deacetylase SIRT1 inhibitor | 0.108 0.107 CID_132263367 | CID_132263367 | |
| 0.05 | 0.447 | 0.109 | DNA repair enzyme inhibitor | 0.109 0.098 CID_132263367 | CID_132263367 | |
| 0.032 | 0.438 | 0.094 | Lanosterol 14 alpha demethylase inhibitor | 0.094 0.065 CID_132263367 | CID_132263367 | |
| 0.019 | 0.427 | 0.082 | Sphingosine 1-phosphate receptor antagonist | 0.082 0.041 CID_132263367 | CID_132263367 | |
| 0.015 | 0.425 | 0.081 | Fatty acid synthase inhibitor | 0.081 0.018 CID_132263367 | CID_132263367 | |
| 0.006 | 0.436 | 0.068 | Prostaglandin-E synthase inhibitor | 0.068 0.051 CID_132263367 | CID_132263367 | |
| 0.099 | 0.53 | 0.455 | 5 Hydroxytryptamine release inhibitor | 0.455 0.049 CID_132263367 | CID_132263367 | |
| 0.03 | 0.461 | 0.118 | DOPA decarboxylase inhibitor | 0.118 0.047 CID_132263367 | CID_132263367 | |
| 0.005 | 0.438 | 0.022 | Alpha 1a adrenoreceptor agonist | 0.022 0.016 CID_2772144 | CID_2772144 | |
| 0.003 | 0.436 | 0.125 | Progesterone antagonist | 0.125 0.007 CID_132263367 | CID_132263367 | |
| 0.044 | 0.482 | 0.195 | 3C-like protease (Human coronavirus) inhibitor | 0.195 0.054 CID_132263367 | CID_132263367 | |
| 0.01 | 0.453 | 0.089 | Pim-3 kinase inhibitor | 0.089 0.06 CID_2772144 | CID_2772144 | |
| 0.027 | 0.472 | 0.137 | Mannose-6-phosphate isomerase inhibitor | 0.137 0.077 CID_2772144 | CID_2772144 | |
| 0.03 | 0.477 | 0.082 | Vanilloid agonist | 0.082 0.064 CID_132263367 | CID_132263367 | |
| 0.009 | 0.458 | 0.116 | Sphingosine 1-phosphate receptor 4 agonist | 0.116 0.018 CID_132263367 | CID_132263367 | |
| 0.098 | 0.55 | 0.292 | 5 Hydroxytryptamine uptake stimulant | 0.292 0.049 CID_132263367 0.234 0.099 CID_2772144 | CID_132263367 | |
| 0.065 | 0.52 | 0.288 | RNA-directed DNA polymerase inhibitor | 0.288 0.034 CID_132263367 | CID_132263367 | |
| 0.096 | 0.551 | 0.321 | Caspase 9 stimulant | 0.321 0.172 CID_132263367 0.316 0.177 CID_2772144 | CID_132263367 | |
| 0.004 | 0.46 | 0.058 | Phosphorylase inhibitor | 0.058 0.026 CID_132263367 | CID_132263367 | |
| 0.023 | 0.482 | 0.114 | HIV-1 integrase (Overall Integration) inhibitor | 0.114 0.043 CID_132263367 | CID_132263367 | |
| 0.01 | 0.47 | 0.061 | Adenylate cyclase 1 inhibitor | 0.061 0.017 CID_132263367 | CID_132263367 | |
| 0.008 | 0.471 | 0.05 | Mineralocorticoid receptor antagonist | 0.05 0.031 CID_132263367 | CID_132263367 | |
| 0.018 | 0.482 | 0.183 | Ferrochelatase inhibitor | 0.183 0.027 CID_132263367 | CID_132263367 | |
| 0.053 | 0.516 | 0.636 | Antiobesity | 0.636 0.016 CID_15959407 | CID_15959407 | |
| 0.026 | 0.494 | 0.087 | NADH dehydrogenase inhibitor | 0.087 0.062 CID_132263367 | CID_132263367 | |
| 0.042 | 0.51 | 0.224 | ATPase inhibitor | 0.224 0.022 CID_132263367 | CID_132263367 | |
| 0.017 | 0.488 | 0.22 | Anesthetic general | 0.22 0.064 CID_132263367 | CID_132263367 | |
| 0.058 | 0.53 | 0.196 | Lipocortins synthesis antagonist | 0.196 0.059 CID_132263367 | CID_132263367 | |
| 0.015 | 0.488 | 0.089 | Nitric-oxide synthase inhibitor | 0.089 0.08 CID_132263367 | CID_132263367 | |
| 0.007 | 0.486 | 0.049 | GABA B receptor antagonist | 0.049 0.02 CID_132263367 | CID_132263367 | |
| 0.025 | 0.504 | 0.106 | Interleukin 8 antagonist | 0.106 0.083 CID_132263367 | CID_132263367 | |
| 0.004 | 0.491 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 CID_132263367 | CID_132263367 | |
| 0.035 | 0.529 | 0.216 | GABA C receptor rho-2 antagonist | 0.216 0.021 CID_132263367 0.13 0.106 CID_2772144 | CID_132263367 | |
| 0.036 | 0.533 | 0.13 | Adenylate cyclase stimulant | 0.13 0.102 CID_132263367 | CID_132263367 | |
| 0.006 | 0.506 | 0.119 | Androgen agonist | 0.119 0.01 CID_132263367 | CID_132263367 | |
| 0.014 | 0.514 | 0.183 | Diuretic | 0.183 0.052 CID_132263367 | CID_132263367 | |
| 0.056 | 0.563 | 0.322 | Vasodilator, peripheral | 0.322 0.086 CID_132263367 | CID_132263367 | |
| 0.023 | 0.538 | 0.082 | MAP kinase kinase 7 inhibitor | 0.082 0.04 CID_2772144 | CID_2772144 | |
| 0.022 | 0.542 | 0.135 | Antineoplastic alkaloid | 0.135 0.032 CID_132263367 | CID_132263367 | |
| 0.025 | 0.546 | 0.11 | TRPA1 agonist | 0.11 0.071 CID_132263367 | CID_132263367 | |
| 0.013 | 0.542 | 0.091 | Potassium channel activator | 0.091 0.059 CID_132263367 | CID_132263367 | |
| 0.014 | 0.546 | 0.067 | Dihydroorotate oxidase inhibitor | 0.067 0.02 CID_132263367 | CID_132263367 | |
| 0.015 | 0.555 | 0.132 | GABA C receptor agonist | 0.106 0.061 CID_132263367 0.132 0.042 CID_2772144 | CID_2772144 | |
| 0.02 | 0.565 | 0.049 | Alpha 1b adrenoreceptor agonist | 0.049 0.037 CID_2772144 | CID_2772144 | |
| 0.011 | 0.559 | 0.071 | Pregnane X receptor antagonist | 0.071 0.013 CID_132263367 | CID_132263367 | |
| 0.033 | 0.583 | 0.167 | Interleukin agonist | 0.167 0.151 CID_132263367 | CID_132263367 | |
| 0.014 | 0.564 | 0.061 | Phosphodiesterase 1A inhibitor | 0.061 0.038 CID_132263367 | CID_132263367 | |
| 0.025 | 0.583 | 0.154 | Pregnane X receptor agonist | 0.154 0.047 CID_132263367 | CID_132263367 | |
| 0.043 | 0.602 | 0.366 | Histamine release inhibitor | 0.366 0.092 CID_132263367 | CID_132263367 | |
| 0.075 | 0.636 | 0.133 | Heat shock protein 70 antagonist | 0.133 0.106 CID_132263367 | CID_132263367 | |
| 0.007 | 0.578 | 0.182 | Androgen antagonist | 0.182 0.016 CID_132263367 | CID_132263367 | |
| 0.014 | 0.595 | 0.085 | Potassium channel (Ca-activated) activator | 0.085 0.069 CID_132263367 | CID_132263367 | |
| 0.006 | 0.588 | 0.079 | Inducible nitric-oxide synthase inhibitor | 0.079 0.063 CID_132263367 | CID_132263367 | |
| 0.012 | 0.595 | 0.181 | GABA C receptor antagonist | 0.181 0.017 CID_132263367 0.097 0.083 CID_2772144 | CID_132263367 | |
| 0.015 | 0.599 | 0.138 | GABA C receptor rho-1 antagonist | 0.138 0.027 CID_132263367 0.096 0.068 CID_2772144 | CID_132263367 | |
| 0.011 | 0.596 | 0.056 | Glucosylceramidase inhibitor | 0.056 0.036 CID_2772144 | CID_2772144 | |
| 0.036 | 0.632 | 0.199 | Gastrin inhibitor | 0.199 0.151 CID_132263367 | CID_132263367 | |
| 0.019 | 0.615 | 0.094 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.06 CID_132263367 | CID_132263367 | |
| 0.032 | 0.629 | 0.142 | Vanilloid 1 agonist | 0.142 0.048 CID_132263367 | CID_132263367 | |
| 0.017 | 0.619 | 0.119 | Bile acid receptor antagonist | 0.119 0.021 CID_132263367 | CID_132263367 | |
| 0.01 | 0.612 | 0.065 | Aldosterone antagonist | 0.065 0.016 CID_132263367 | CID_132263367 | |
| 0.019 | 0.623 | 0.119 | Aldehyde dehydrogenase inhibitor | 0.119 0.072 CID_132263367 | CID_132263367 | |
| 0.013 | 0.622 | 0.09 | UDP-glucose 4-epimerase inhibitor | 0.09 0.074 CID_132263367 | CID_132263367 | |
| 0.002 | 0.613 | 0.029 | Nicotinic acid receptor 2 antagonist | 0.029 0.015 CID_132263367 | CID_132263367 | |
| 0.014 | 0.625 | 0.125 | Heat shock protein 90 alpha antagonist | 0.125 0.119 CID_132263367 | CID_132263367 | |
| 0.003 | 0.618 | 0.034 | Thyroid hormone agonist | 0.034 0.009 CID_132263367 | CID_132263367 | |
| 0.019 | 0.634 | 0.128 | Sphingosine 1-phosphate receptor 4 antagonist | 0.128 0.058 CID_132263367 | CID_132263367 | |
| 0.02 | 0.635 | 0.165 | Succinate dehydrogenase inhibitor | 0.165 0.087 CID_132263367 | CID_132263367 | |
| 0.034 | 0.652 | 0.198 | Superoxide dismutase inhibitor | 0.198 0.119 CID_2772144 | CID_2772144 | |
| 0.011 | 0.632 | 0.141 | MAP kinase kinase 2 inhibitor | 0.141 0.13 CID_132263367 | CID_132263367 | |
| 0.037 | 0.663 | 0.185 | Immunomodulator | 0.185 0.181 CID_132263367 | CID_132263367 | |
| 0.003 | 0.639 | 0.049 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 CID_2772144 | CID_2772144 | |
| 0.021 | 0.661 | 0.121 | Photosensitizer | 0.121 0.055 CID_132263367 | CID_132263367 | |
| 0.023 | 0.674 | 0.094 | Glutamate (mGluR7) agonist | 0.094 0.074 CID_132263367 | CID_132263367 | |
| 0.031 | 0.682 | 0.156 | Neurotensin receptor agonist | 0.156 0.088 CID_132263367 | CID_132263367 | |
| 0.007 | 0.664 | 0.072 | GABA aminotransferase inhibitor | 0.072 0.059 CID_132263367 | CID_132263367 | |
| 0.019 | 0.688 | 0.127 | Melanin inhibitor | 0.127 0.12 CID_132263367 | CID_132263367 | |
| 0.006 | 0.677 | 0.069 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.069 0.062 CID_132263367 | CID_132263367 | |
| 0.006 | 0.68 | 0.1 | Alcohol dehydrogenase inhibitor | 0.1 0.052 CID_132263367 | CID_132263367 | |
| 0.003 | 0.679 | 0.041 | Dihydrofolate reductase inhibitor | 0.041 0.038 CID_132263367 | CID_132263367 | |
| 0.013 | 0.693 | 0.099 | Anabolic | 0.099 0.064 CID_132263367 | CID_132263367 | |
| 0.013 | 0.696 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.113 CID_132263367 | CID_132263367 | |
| 0.011 | 0.695 | 0.116 | Alpha-N-acetylglucosaminidase inhibitor | 0.116 0.082 CID_132263367 0.109 0.089 CID_2772144 | CID_132263367 | |
| 0.021 | 0.729 | 0.204 | Cholesterol antagonist | 0.204 0.161 CID_132263367 | CID_132263367 | |
| 0.013 | 0.728 | 0.188 | DNA synthesis inhibitor | 0.184 0.147 CID_132263367 0.188 0.142 CID_2772144 | CID_2772144 | |
| 0.021 | 0.744 | 0.137 | Interferon gamma antagonist | 0.137 0.098 CID_132263367 | CID_132263367 | |
| 0.007 | 0.773 | 0.133 | Arachidonic acid antagonist | 0.133 0.109 CID_132263367 | CID_132263367 | |
| 0.002 | 0.779 | 0.059 | Free fatty acid receptor 1 agonist | 0.059 0.004 CID_15959407 | CID_15959407 | |
| 0.011 | 0.793 | 0.13 | Interleukin 6 antagonist | 0.13 0.124 CID_132263367 | CID_132263367 | |
| 0.018 | 0.809 | 0.656 | Cyclophilin D inhibitor | 0.656 0.019 CID_15959407 | CID_15959407 | |
| 0.012 | 0.807 | 0.119 | Farnesoid X receptor antagonist | 0.119 0.106 CID_132263367 | CID_132263367 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |